What is Medtronic Pain Interventions's cybersecurity risk score?

Medtronic Pain Interventions has an AI-generated cybersecurity risk score of 765 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Medtronic Pain Interventions experienced?

According to Rankiteo, Medtronic Pain Interventions currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Medtronic Pain Interventions been affected by any supply chain cyber incidents ?

According to Rankiteo, Medtronic Pain Interventions has been affected by multiple supply chain cyber incidents. The affected supply chain sources and their corresponding incident IDs are: Snowflake (Incident ID: DEN1779855877) LiteLLM (Incident ID: AGOBOO1776904233) Anodot by Glassbox (Incident ID: MED1777300385)

Does Medtronic Pain Interventions have SOC 2 Type 1 certification ?

According to Rankiteo, Medtronic Pain Interventions is not certified under SOC 2 Type 1.

Does Medtronic Pain Interventions have SOC 2 Type 2 certification ?

According to Rankiteo, Medtronic Pain Interventions does not hold a SOC 2 Type 2 certification.

Does Medtronic Pain Interventions comply with GDPR ?

According to Rankiteo, Medtronic Pain Interventions is not listed as GDPR compliant.

Does Medtronic Pain Interventions have PCI DSS certification ?

According to Rankiteo, Medtronic Pain Interventions does not currently maintain PCI DSS compliance.

Does Medtronic Pain Interventions comply with HIPAA ?

According to Rankiteo, Medtronic Pain Interventions is not compliant with HIPAA regulations.

Does Medtronic Pain Interventions have ISO 27001 certification ?

According to Rankiteo,Medtronic Pain Interventions is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Medtronic Pain Interventions operate in ?

Medtronic Pain Interventions operates primarily in the Medical Equipment Manufacturing industry.

How many employees does Medtronic Pain Interventions have ?

Medtronic Pain Interventions employs approximately None employees people worldwide.

Does Medtronic Pain Interventions own any subsidiaries ?

Medtronic Pain Interventions presently has no subsidiaries across any sectors.

How many LinkedIn followers does Medtronic Pain Interventions have ?

Medtronic Pain Interventions's official LinkedIn profile has approximately 22,772 followers.

What is the NAICS classification code for Medtronic Pain Interventions ?

Medtronic Pain Interventions is classified under the NAICS code 3391, which corresponds to Medical Equipment and Supplies Manufacturing.

Does Medtronic Pain Interventions have a Crunchbase profile ?

No, Medtronic Pain Interventions does not have a profile on Crunchbase.

Does Medtronic Pain Interventions have a LinkedIn profile ?

Yes, Medtronic Pain Interventions maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/medtronicpaininterventions.

How many cybersecurity incidents has Medtronic Pain Interventions experienced ?

As of September 17, 2026, Rankiteo reports that Medtronic Pain Interventions has experienced 8 cybersecurity incidents.

How many peer or competitor companies does Medtronic Pain Interventions have ?

Medtronic Pain Interventions has an estimated 5,963 peer or competitor companies worldwide.

What types of cybersecurity incidents has Medtronic Pain Interventions faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Breach, Vulnerability and Cyber Attack.

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

MPI

Boost Score +25 with badge (5 left)

765

/1000

Fair

790

/1000

Fair

Medtronic Pain Interventions Vendor Cyber Rating & Cyber Score

medtronic.com

Add Your Compliance Badge

A global healthcare technology leader — boldly attacking the most challenging health problems facing humanity with innovations that transform lives.

MPI

Medtronic Pain Interventions CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

Medtronic

Breach

5/2026

Snowflake

DEN1779855877

Medtronic

Vulnerability

4/2026

GOOMICMED177765...

Medtronic

Breach

4/2026

LiteLLM

AGOBOO177690423...

Medtronic

Cyber Attack

4/2026

Anodot by Glass...

MED1777300385

Medtronic

Breach

4/2026

MED1782930445

Medtronic

Breach

2/2026

MEDINTSTR177714...

Medtronic

Cyber Attack

100

2/2026

MED1777459592

Medtronic Pain Inte...

Breach

9/2020

MED742080425

Loading…

A.I.

MPI Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for MPI

Incidents vs Medical Equipment Manufacturing Industry Avg (This Year)

No incidents recorded for Medtronic Pain Interventions in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Medtronic Pain Interventions in 2026.

Incident Types MPI vs Medical Equipment Manufacturing Industry Avg (This Year)

No incidents recorded for Medtronic Pain Interventions in 2026.

Incident History - MPI (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Medtronic Pain Interventions Subsidiaries

MPI

Medical Equipment Manufacturing

Website: https://www.medtronic.com/us-en/healthcare-professionals/therapies-procedures/neurological/spinal-cord-stimulation.html?cmpid=vanity_url_medtronic_com_scs_RTG_Neuro_FY22

Company Size: 10,001+ employees

MedtronicMedical Equipment Manufacturing

Medtronic SparkNon-profit Organizations

Medtronic Ear, Nose & ThroatMedical Equipment Manufacturing

Covidien (Medtronic Minimally Invasive Therapies Group)Medical Equipment Manufacturing

Medtronic Cardiac and Vascular Medical Device

Medtronic Robotic-Assisted SurgeryMedical Equipment Manufacturing

Medtronic Surgical InnovationsMedical Device

Loading…

Medtronic Pain Interventions Similar Companies

Smith+Nephew

smith-nephew.com

Smith+Nephew is a global medical technology company. We design and manufacture technology that takes the limits off living. We support healthcare professionals to return their patients to health and mobility, helping them to perform at their fullest potential. From our first employee and founder, T.J. Smith, to our team today, it’s our people who make Smith+Nephew a unique place. Yes, we love to innovate and develop exciting technologies, and we offer competitive salaries and progressive benefits. But it’s our culture - of Care, Collaboration and Courage - that really sets us apart. Through a spirit of ownership and can-do attitude, we work together to win.. We’re a company of people who care about each other, about our customers and their patients, and about our communities. Together, we fulfill our shared purpose of Life Unlimited. Please note: not all products referred to may be approved for use or available in all markets.

Stryker

stryker.com

Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 150 million patients annually. More information is available at stryker.com and careers.stryker.com. Facts: ● 2024 Sales: $22.6 billion ● Industry: Medical Instruments & Supplies ● Employees: 53,000 worldwide ● 44+ Manufacturing and R&D Locations Worldwide ● $1.5 billion spent on research and development in 2024 ● ~14,200 patents owned globally in 2024 ● Products sold in ~75 countries ● Fortune 500 Company ● 9 consecutive years as one a World's Best Workplace Stryker’s social media community guidelines: https://www.stryker.com/content/m/legal/social-media-community-guidelines/en/index.html Notice Regarding Employee Conduct on Facebook/LinkedIn Meta/LinkedIn does not permit employers to verify or validate “employees” in the (META: “Works at” LinkedIn: “Experience”) section of users’ profiles. Please be aware that the views expressed by individuals on their personal accounts and do not necessarily represent the views of our company. If you encounter any issues with a person claiming to be our employee, we recommend using the “Report Profile” feature. If you’d like to report concerns to our Ethics Hotline, you may do so at: https://app.convercent.com/en-us/LandingPage/b6bb4e84-9fcb-ea11-a974-000d3ab9f296

Alcon

alcon.com

Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people’s lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 25,000 associates are enhancing the quality of life through innovative products, partnerships with Eye Care Professionals and programs that advance access to quality eye care. Learn more at www.alcon.com.

Edwards Lifesciences

edwards.com

Edwards Lifesciences (NYSE: EW), is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most. We thrive on discovery and expanding the boundaries of medical technology, serving patients in 100+ countries, with the help of our employees in areas including Clinical Affairs, Quality Engineering, Research & Development, Regulatory Affairs, Sales & Marketing, corporate functions and more. Contact Us We want to hear from you and engage in meaningful discussions. However, please note that we are not equipped to provide customer, candidate, or technical support through this platform. If you require assistance from those teams, please find their contact information here: https://www.edwards.com/aboutus/contactus If you’re a patient in need of medical advice, please contact your healthcare provider directly. We reserve the right to remove any comments that are off-topic, repetitive, or include hate speech, profanity, or offensive language. Additionally, we will not engage in discussions about competitor products, off-label use of Edwards products, or unsubstantiated/misleading claims that could cause harm. All Terms and Conditions of LinkedIn apply. For the Edwards Lifesciences privacy policy, visit https://www.edwards.com/legal/privacypolicy.

Baxter International Inc.

baxter.com

For nearly a century, we have delivered on our commitment to saving and sustaining the lives of patients, working alongside clinicians and providers around the world. We believe every person — regardless of who they are or where they are from — deserves a chance to live a healthy life, free from illness and full of possibility. At the intersection of progress and purpose is where we are redefining what it means to be a global medtech leader. It is where we are relentlessly pursuing healthcare transformation, fueled by our compassion for patients and providers and the challenges they face. It is where bold ideas meet the promise for meaningful change in the world around us. We are there, at every step of the journey, to help clinicians deliver the best care possible.

Henry Schein

henryschein.com

Henry Schein, Inc. (Nasdaq: HSIC) is a products, services, and technology platforms company for healthcare customers. With more than 25,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional healthcare clinics, as well as other alternate care sites. Henry Schein operates through a centralized and automated distribution network, with a selection of more than 300,000 branded products and Henry Schein corporate brand products in our distribution centers. A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 34 countries and territories. The Company's sales reached $13.2 billion in 2025, and have grown at a compound annual rate of approximately 11.0 percent since Henry Schein became a public company in 1995.

Danaher Corporation

danaher.com

Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. We partner with customers across the globe to help them solve their most complex challenges, architecting solutions that bring the power of science to life. Our global teams are pioneering what’s next across Life Sciences, Diagnostics, Biotechnology and beyond. For more information, visit www.danaher.com.

STERIS

steris.com

STERIS is a leading provider of infection prevention and other procedural products and services, focused primarily on healthcare, pharmaceutical and medical device Customers. MISSION WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science products and services around the globe. VISION We strive to be a GREAT COMPANY. We provide world-class products and services for our Customers, safe and rewarding work for our people, and superior returns for our Shareholders. • $5 Billion in revenue in FY24 • More than 17,000 Associates worldwide • Over 4,000 Customer-facing professionals • Listed on the New York Stock Exchange under the symbol “STE” To learn more, visit www.steris.com. Want to join the team? View and apply for open roles at careers.steris.com.

Zimmer Biomet

zimmerbiomet.com

Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We advance our mission to alleviate pain and improve the quality of life for patients around the world with our innovative products and suite of integrated digital and robotic technologies leverage data, data analytics and artificial intelligence. Founded in 1927 and based in Warsaw, Zimmer Biomet has operations in more than 25 countries and sales in more than 100 countries. We maintain world-class scientific facilities and resources and collaborate with leading clinicians and researchers around the world. Awards and Recognitions • Forbes: America's Best Companies 2026 • Workhuman: Luminary Award 2025 & Innovator Award 2024 • TIME: America's Best Companies [Mid-Size] 2024 • Great Place to Work - Best Workplaces: Switzerland & Poland 2025 • Great Place to Work Certified 2025 - 2026: USA, Poland, India, Colombia, Ireland, Puerto Rico, Kingdom of Saudi Arabia, Switzerland • MedTech: Breakthrough Award Best New Technology Solution in Orthopedics 2025 • Top Employers Institute: China 2025 • VETS Indexes: 4 Star Employer 2025

Loading…

NEWS

Medtronic Pain Interventions CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

October 22, 2024 07:00 AM

Pain Management Devices Market Report 2024 and Company Benchmarking for Abbott, Medtronic, Zynex Medical, Boston Scientific and OMRON Healthcare

Pain Management Devices - Company Competitiveness Analysis Pain Management Devices - Company Competitiveness Analysis Pain Management...

Read Article

October 10, 2023 07:00 AM

FDA Approves Medtronic’s SynchroMed III Pain Pump

Medtronic has received U.S. Food and Drug Administration (FDA) approval for its next-gen SynchroMed III intrathecal drug delivery system for...

Read Article

October 10, 2023 07:00 AM

FDA approves next-gen intrathecal drug delivery system from Medtronic

The medtech giant designed SynchroMed III to treat patients with chronic pain, cancer pain and severe spasticity.

Read Article

September 22, 2022 07:00 AM

Medtronic MiniMed 600 Insulin Pump Has Potentially Deadly Cybersecurity Problem, FDA Warns

The FDA warns of potentially fatal cybersecurity flaws linked to the Medtronic MiniMed 600 Series Insulin Pump System.

Read Article

September 20, 2022 07:00 AM

Medtronic, FDA warn on potential cybersecurity risk with MiniMed insulin pump

Medtronic issued an urgent medical device correction notice to warn of potential issues with some MiniMed automated insulin delivery...

Read Article

October 25, 2018 07:00 AM

Medtronic’s dose-controlling app for pain pump gets FDA nod

Medtronic's SynchroMed is designed to enable patients suffering from chronic pain to stop taking systemic opioids.

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-65388

SUMMARY

A remote attacker who controls a container registry may be able to direct a client's token request to a host of the attacker's choice, and disclose the victim's registry credentials to that host. This vulnerability is addressed in containerization version 0.41.0.

Published

Date2026-09-16

Updated

Date2026-09-16

RISK INFORMATION (Score: )

Impact Score

Exploitability

REFERENCES

https://github.com/apple/containerization/security/advisories/GHSA-mx96-5vvg-x2mg

CVE-2026-61599

SUMMARY

djust provides Phoenix LiveView-style reactive server-side rendering for Django with Rust-powered performance. Prior to version 1.0.7, the djust live transport resolves the LiveView to mount from a client-supplied dotted path by calling `__import__(module_path, ...)`. The module is imported — running its top-level code (import side effects) — before the framework checks that the resolved object is a `LiveView` subclass and before any per-view authentication. The `LIVEVIEW_ALLOWED_MODULES` allowlist that should contain this is fail-open (`if allowed_modules:` — skipped when the setting is unset, the framework default) and uses loose `startswith` matching. An unauthenticated WebSocket client (the WS handshake does not require auth; per-view auth runs only after import + instantiate) can therefore send a `mount` / `live_redirect_mount` / `url_change` frame (or an SSE mount) with `view = "<any.importable.module>.AnyName"` and cause the server to import — and execute the top-level code of — any importable Python module by name. Version 1.0.7 fixes the issue with a fail-closed resolution gate (`djust._view_resolution.is_view_import_allowed`): a client view path resolves only if (a) its module is already loaded (`sys.modules` — so resolving runs no new code; URL-routed views loaded by URLconf at startup keep working with zero config) or (b) it matches `LIVEVIEW_ALLOWED_MODULES` on a module-segment boundary (explicit opt-in for lazily-imported views). The gate runs before `__import__` at all three sinks (+ defense-in-depth inside `_instantiate_view`). As a workaround, set `LIVEVIEW_ALLOWED_MODULES` to the narrow list of modules that contain your mountable LiveView classes. (Note: pre-patch the allowlist is `startswith`-matched and the import still precedes the subclass check, so this is mitigation, not a complete fix.)

Published

Date2026-09-16

Updated

Date2026-09-16

RISK INFORMATION (Score: )

cvss4

Base Score: 8.8

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:H/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

CVE-2026-61596

SUMMARY

djust provides Phoenix LiveView-style reactive server-side rendering for Django with Rust-powered performance. Prior to version 1.0.7, djust's per-object authorization (`get_object` + `has_object_permission`, ADR-017) was enforced on the WebSocket mount and event paths but not on three other render entry points: (a) the initial HTTP GET render, (b) SPA `url_change` navigation, and (c) `{% live_render %}` embedded child views. An authenticated user could therefore view (and on some paths act on) an object they are not authorized for by loading the page directly, navigating to it via SPA url-change, or composing it as an embedded child — a classic IDOR / broken object-level access control on object-scoped views. This is fixed in djust 1.0.7. All render entry points now route through a shared `enforce_object_permission` chokepoint: HTTP GET returns 403, `url_change` emits a `permission_denied` frame and skips the render, and `{% live_render %}` (eager + lazy) refuses the embed. Views without a custom `get_object` are unaffected (no-op). No reliable workaround short of upgrading. Do not expose object-scoped views through the HTTP-GET / url_change / live_render paths until patched.

Published

Date2026-09-16

Updated

Date2026-09-16

RISK INFORMATION (Score: 7.1)

cvss3

Base Score: 7.1

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:L/A:N

Impact Score

4.2

Exploitability

2.8

REFERENCES

CVE-2026-61589

SUMMARY

djust provides Phoenix LiveView-style reactive server-side rendering for Django with Rust-powered performance. Prior to version 1.0.7, the WebSocket `handle_mount` and `ViewRuntime._build_request` rebuild an `HttpRequest` via `RequestFactory().get(...)` with no `HTTP_HOST`, so `request.get_host()` defaulted to `"testserver"` on the live path. Host/subdomain/domain `TenantResolver`s then misresolved the tenant — `None` on the live path while the HTTP path resolved correctly. With `STRICT_MODE=False` the tenant-scoped managers returned unscoped rows (cross-tenant disclosure); with the default they returned an empty queryset (broken tenancy). This is fixed in djust 1.0.7. The handshake Host is extracted from the ASGI scope, validated against `ALLOWED_HOSTS` (the same logic as the CSWSH Origin gate, parsed with Django's `split_domain_port` so malformed Hosts are rejected at the boundary), and propagated — with the TLS scheme — into the reconstructed request, so live-path tenant resolution matches HTTP exactly. There is no known workaround on the live path short of upgrading. Users are most exposed when combined with `STRICT_MODE=False`.

Published

Date2026-09-16

Updated

Date2026-09-16

RISK INFORMATION (Score: 6.3)

cvss3

Base Score: 6.3

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:C/C:H/I:N/A:N

Impact Score

Exploitability

1.8

REFERENCES

CVE-2026-61588

SUMMARY

djust provides Phoenix LiveView-style reactive server-side rendering for Django with Rust-powered performance. Prior to version 1.0.7, when a Django `Model` instance is assigned to a public view attribute, djust serialized it to the client with no sensitive-field denylist — sending fields such as `password` (the hash), privilege flags (e.g. `is_staff` / `is_superuser`), tokens, and other PII to the browser. Because exposing model objects to templates is a normal djust pattern, this could leak credentials/PII without the developer realizing the full object crossed the wire. This is fixed in djust 1.0.7. Model serialization applies a secure-by-default sensitive-field denylist (password/hash/token/secret-style fields and known privilege flags are withheld) with an identity-subset fallback. As a workaround, keep `Model` instances on `_private` attributes and expose only the specific fields needed, until patched.

Published

Date2026-09-16

Updated

Date2026-09-16

RISK INFORMATION (Score: 6.5)

cvss3

Base Score: 6.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N

Impact Score

3.6

Exploitability

2.8

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…

Badge your company to reduce your risk score and your cyber insurance costs!

Trusted by insurers. Chosen by leaders.

Medtronic Pain Interventions Vendor Cyber Rating & Cyber Score

MPI A.I CyberSecurity Scoring

Medtronic Pain Interventions CyberSecurity News & History

MPI Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for MPI

Incidents vs Medical Equipment Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types MPI vs Medical Equipment Manufacturing Industry Avg (This Year)

Incident History - MPI (X = Date, Y = Severity)

Medtronic Pain Interventions Subsidiaries

MPI

Medtronic Pain Interventions Similar Companies

Smith+Nephew

Stryker

Alcon

Edwards Lifesciences

Baxter International Inc.

Henry Schein

Danaher Corporation

STERIS

Zimmer Biomet

Medtronic Pain Interventions CyberSecurity News

Pain Management Devices Market Report 2024 and Company Benchmarking for Abbott, Medtronic, Zynex Medical, Boston Scientific and OMRON Healthcare

FDA Approves Medtronic’s SynchroMed III Pain Pump

FDA approves next-gen intrathecal drug delivery system from Medtronic

Medtronic MiniMed 600 Insulin Pump Has Potentially Deadly Cybersecurity Problem, FDA Warns

Medtronic, FDA warn on potential cybersecurity risk with MiniMed insulin pump

Medtronic’s dose-controlling app for pain pump gets FDA nod

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo

Medtronic Pain Interventions CyberSecurity News & History

MPI Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for MPI

Incidents vs Medical Equipment Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types MPI vs Medical Equipment Manufacturing Industry Avg (This Year)

Incident History - MPI (X = Date, Y = Severity)

Medtronic Pain Interventions Subsidiaries

MPI

Medtronic Pain Interventions Similar Companies

Smith+Nephew

Stryker

Alcon

Edwards Lifesciences

Baxter International Inc.

Henry Schein

Danaher Corporation

STERIS

Zimmer Biomet

Medtronic Pain Interventions CyberSecurity News

Pain Management Devices Market Report 2024 and Company Benchmarking for Abbott, Medtronic, Zynex Medical, Boston Scientific and OMRON Healthcare

FDA Approves Medtronic’s SynchroMed III Pain Pump

FDA approves next-gen intrathecal drug delivery system from Medtronic

Medtronic MiniMed 600 Insulin Pump Has Potentially Deadly Cybersecurity Problem, FDA Warns

Medtronic, FDA warn on potential cybersecurity risk with MiniMed insulin pump

Medtronic’s dose-controlling app for pain pump gets FDA nod

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo